GSK plc
GSK
#228
Rank
C$137.21 B
Marketcap
C$68.45
Share price
-0.13%
Change (1 day)
5.72%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): C$4.03

According to GSK plc's latest financial reports the company's current EPS (TTM) is C$4.12. In 2025 the company made an earnings per share (EPS) of C$5.40 an increase over its 2024 EPS that were of C$2.28.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.03-25.3%
2025C$5.40136.36%
2024C$2.28-47.35%
2023C$4.34-64.2%
2022C$12.12182.29%
2021C$4.29-18.07%
2020C$5.2422.34%
2019C$4.2823.9%
2018C$3.46140.61%
2017C$1.4464.45%
2016C$0.87-90.61%
2015C$9.30178.12%
2014C$3.35-48.11%
2013C$6.4522.68%
2012C$5.26-11.31%
2011C$5.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.52 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-75.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-31.17%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$1.42-65.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.20 147.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.64-84.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
C-$0.46-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA